1. Home
  2. HGBL vs PYXS Comparison

HGBL vs PYXS Comparison

Compare HGBL & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGBL
  • PYXS
  • Stock Information
  • Founded
  • HGBL 1937
  • PYXS 2018
  • Country
  • HGBL United States
  • PYXS United States
  • Employees
  • HGBL N/A
  • PYXS N/A
  • Industry
  • HGBL Business Services
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HGBL Consumer Discretionary
  • PYXS Health Care
  • Exchange
  • HGBL Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • HGBL 81.0M
  • PYXS 76.1M
  • IPO Year
  • HGBL N/A
  • PYXS 2021
  • Fundamental
  • Price
  • HGBL $2.03
  • PYXS $1.28
  • Analyst Decision
  • HGBL
  • PYXS Strong Buy
  • Analyst Count
  • HGBL 0
  • PYXS 6
  • Target Price
  • HGBL N/A
  • PYXS $9.20
  • AVG Volume (30 Days)
  • HGBL 51.8K
  • PYXS 551.2K
  • Earning Date
  • HGBL 03-13-2025
  • PYXS 03-20-2025
  • Dividend Yield
  • HGBL N/A
  • PYXS N/A
  • EPS Growth
  • HGBL N/A
  • PYXS N/A
  • EPS
  • HGBL 0.27
  • PYXS N/A
  • Revenue
  • HGBL $49,878,000.00
  • PYXS $16,146,000.00
  • Revenue This Year
  • HGBL N/A
  • PYXS N/A
  • Revenue Next Year
  • HGBL $19.47
  • PYXS N/A
  • P/E Ratio
  • HGBL $7.50
  • PYXS N/A
  • Revenue Growth
  • HGBL N/A
  • PYXS N/A
  • 52 Week Low
  • HGBL $1.52
  • PYXS $1.23
  • 52 Week High
  • HGBL $3.09
  • PYXS $6.85
  • Technical
  • Relative Strength Index (RSI)
  • HGBL 41.96
  • PYXS 32.91
  • Support Level
  • HGBL $2.20
  • PYXS $1.23
  • Resistance Level
  • HGBL $2.32
  • PYXS $1.40
  • Average True Range (ATR)
  • HGBL 0.09
  • PYXS 0.09
  • MACD
  • HGBL -0.03
  • PYXS 0.00
  • Stochastic Oscillator
  • HGBL 37.50
  • PYXS 15.15

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: